1.A case of Hutchinson Gilford Progeria Syndrome.
Myung Ho CHO ; Yong Woo CHOI ; Wan Seob KIM ; Oh Kyung LEE ; Myung Ho LEE
Journal of the Korean Pediatric Society 1986;29(5):106-110
No abstract available.
Progeria*
2.A Case of Hutchinson-Gilford Progeria Syndrome.
Journal of the Korean Pediatric Society 1986;29(10):90-94
No abstract available.
Progeria*
3.A Case of Hutchinson-Gilford Progeria Syndrome.
Seon Ock KHANG ; Jung Hee LEE ; In Joon SEOL ; Gwi Jong CHOI ; Keun Soo LEE
Journal of the Korean Pediatric Society 1985;28(4):405-410
No abstract available.
Progeria*
4.Hutchinson-Gilford progeria syndrome.
Moon Whan LEE ; Byoung Geun LEE ; Pyung Han HWANG ; Dae Yeol LEE ; Jung Soo KIM
Journal of the Korean Pediatric Society 1992;35(7):971-977
No abstract available.
Progeria*
5.Progeria Syndrome.
Journal of the Korean Geriatrics Society 2002;6(3):177-182
No abstract available.
Progeria*
6.The use of peripheral nerve block and intra-articular steroid injection for pain management in an adolescent with Hutchinson-Gilford Progeria Syndrome: A case report
Marie Christelle S. Endencia ; Karl Matthew C. Sy Su ; Catherine Renee B. Reyes
Acta Medica Philippina 2024;58(9):39-43
Hutchinson-Gilford Progeria Syndrome (HGPS) is a rare genetic disorder causing accelerated aging and agerelated pathologies. Weighing benefits and risks on doing surgical versus conservative pain management require multidisciplinary planning and consideration in HGPS patients. This presents a case of a 15-year-old patient with HGPS with severe pain from bilateral hip dislocation managed with peripheral nerve block and steroid injection. This afforded her immediate pain relief allowing her to undergo physical rehabilitation comfortably.
Progeria
;
Anesthesia
9.Hutchinson-Gilford Progeria Syndrome with G608G LMNA Mutation.
Hui Kwon KIM ; Jong Yoon LEE ; Eun Ju BAE ; Phil Soo OH ; Won Il PARK ; Dong Sung LEE ; Jong Il KIM ; Hong Jin LEE
Journal of Korean Medical Science 2011;26(12):1642-1645
Hutchinson-Gilford progeria syndrome (HGPS) is a rare condition originally described by Hutchinson in 1886. Death result from cardiac complications in the majority of cases and usually occurs at average age of thirteen years. A 4-yr old boy had typical clinical findings such as short stature, craniofacial disproportion, alopecia, prominent scalp veins and sclerodermatous skin. This abnormal appearance began at age of 1 yr. On serological and hormonal evaluation, all values are within normal range. He was neurologically intact with motor and mental development. An echocardiogram showed calcification of aortic and mitral valves. Hypertrophy of internal layer at internal carotid artery suggesting atherosclerosis was found by carotid doppler sonography. He is on low dose aspirin to prevent thromboembolic episodes and on regular follow up. Gene study showed typical G608G (GGC- > GGT) point mutation at exon 11 in LMNA gene. This is a rare case of Hutchinson-Gilford progeria syndrome confirmed by genetic analysis in Korea.
Child, Preschool
;
Humans
;
Lamin Type A/*genetics
;
Male
;
Point Mutation
;
Progeria/diagnosis/*genetics
;
Prognosis
;
Republic of Korea
10.Generation of a Hutchinson-Gilford progeria syndrome monkey model by base editing.
Fang WANG ; Weiqi ZHANG ; Qiaoyan YANG ; Yu KANG ; Yanling FAN ; Jingkuan WEI ; Zunpeng LIU ; Shaoxing DAI ; Hao LI ; Zifan LI ; Lizhu XU ; Chu CHU ; Jing QU ; Chenyang SI ; Weizhi JI ; Guang-Hui LIU ; Chengzu LONG ; Yuyu NIU
Protein & Cell 2020;11(11):809-824
Many human genetic diseases, including Hutchinson-Gilford progeria syndrome (HGPS), are caused by single point mutations. HGPS is a rare disorder that causes premature aging and is usually caused by a de novo point mutation in the LMNA gene. Base editors (BEs) composed of a cytidine deaminase fused to CRISPR/Cas9 nickase are highly efficient at inducing C to T base conversions in a programmable manner and can be used to generate animal disease models with single amino-acid substitutions. Here, we generated the first HGPS monkey model by delivering a BE mRNA and guide RNA (gRNA) targeting the LMNA gene via microinjection into monkey zygotes. Five out of six newborn monkeys carried the mutation specifically at the target site. HGPS monkeys expressed the toxic form of lamin A, progerin, and recapitulated the typical HGPS phenotypes including growth retardation, bone alterations, and vascular abnormalities. Thus, this monkey model genetically and clinically mimics HGPS in humans, demonstrating that the BE system can efficiently and accurately generate patient-specific disease models in non-human primates.
Animals
;
Disease Models, Animal
;
Female
;
Gene Editing
;
Humans
;
Lamin Type A/metabolism*
;
Macaca fascicularis
;
Progeria/pathology*